"You can become a crucial part of the future of medicine and scientific advancements. With over 15 years of delivering world-class phase II and phase III clinical research for pharmaceutical companies; AMR Conventions Research has been raising the bar on industry standards for more than a decade; all while setting its sights on the future of how we can help improve and extend patients’ lives."

During the past decade, AMR Conventions Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AMR Conventions Research" #1 sponsor was "Sunovion" with 2 trials, followed by "Supernus Pharmaceuticals, Inc." with 2 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored and "Shire" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AMR Conventions Research" #1 collaborator was "Takeda" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AMR Conventions Research" are "Depressive Episodes, Bipolar I Depression" (2 trials), "Attention Deficit Hyperactivity Disorder" (1 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials), "Attention-deficit/Hyperactivity Disorder" (1 trials) and "Borderline Personality Disorder" (1 trials). Many other conditions were trialed in "AMR Conventions Research" in a lesser frequency.

Most popular intervention types in "AMR Conventions Research" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "SPN-810" (2 trials), "Brexpiprazole" (1 trials), "Fluoxetine 20mg/day" (1 trials) and "Lisdexamfetamine dimesylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "AMR Conventions Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "AMR Conventions Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in AMR Conventions Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AMR Conventions Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".